Skip to content
CritLit
  • Trial Summaries
  • About

A living repository of influential literature in critical care medicine

Browse the latest summaries here or explore by condition or topic below.

TICH-2

Published May 14, 2018 in The Lancet
Intracerebral HemorrhageHemostasis Tranexamic Acid Anti-fibrinolytic Therapy

In adult patients with acute spontaneous intracerebral hemorrhage treated within 8 hours of onset, does tranexamic acid, compared with placebo, improve functional outcome (mRS score) at 90 days?

SWITCH

Published April 13, 2024 in The Lancet
Intracerebral HemorrhageNeurosurgical Intervention Hematoma Evacuation Minimally Invasive Surgery Craniotomy

In adult patients (≥18 years) with spontaneous supratentorial intracerebral hemorrhage (volume 10-60 mL, GCS 5-12, pre-ICH mRS 0-1), does early surgical hematoma evacuation (within 24 hours) plus medical care, compared with initial conservative medical care alone, improve functional outcome (mRS score) at 180 days?

STOP-AUST

Published October 29, 2020 in The Lancet Neurology
Intracerebral HemorrhageHemostasis Tranexamic Acid Anti-fibrinolytic Therapy Hematoma Expansion Imaging Biomarkers

In adult patients with acute spontaneous intracerebral hemorrhage and a CT angiography spot sign, treated within 4.5 hours of onset, does tranexamic acid, compared with placebo, reduce hematoma expansion at 24 hours?

STICH-II

Published July 20, 2013 in The Lancet
Intracerebral HemorrhageNeurosurgical Intervention Hematoma Evacuation

In adult patients with spontaneous superficial lobar intracerebral hemorrhage (10-100 mL, GCS ≥6T/7), does a policy of early surgical hematoma evacuation by craniotomy plus best medical treatment, compared with best medical treatment alone (with delayed surgery if needed), improve outcome at 6 months?

View All Trials

Explore by Condition

  • Acute Ischemic Stroke
  • Intracerebral Hemorrhage
  • Subarachnoid Hemorrhage

Explore by Topic

  • Acute Blood Pressure Control
  • Anti-fibrinolytic Therapy
  • Anticoagulant Reversal
  • Anticoagulation Reversal
  • Antiplatelet Therapy Complications
  • Craniotomy
  • Deferoxamine
  • External Ventricular Drain (EVD)
  • Factor VIIa
  • Fever Prevention
  • Fresh Frozen Plasma (FFP)
  • Glucose Control
  • Hematoma Evacuation
  • Hematoma Expansion
  • Hemostasis
  • Imaging Biomarkers
  • Insulin Therapy
  • Intraventricular Hemorrhage
  • Iron Chelation
  • Ischemic Stroke Management
  • Minimally Invasive Surgery
  • Neurocritical Care
  • Neuroprotection
  • Neurosurgical Intervention
  • Prothrombin Complex Concentrate (PCC)
  • Reversal Agents
  • Secondary Brain Injury
  • Supportive Care
  • Temperature Management
  • Thrombolysis (Alteplase)
  • Tranexamic Acid
  • Warfarin Reversal
© 2025 CritLit 0.5 Trial Summaries Privacy
Atom Feed Github

Theme

Made with by Nikhil Patel